CME: Obesity-Related OSA & Tirzepatide in Pulmonology

Created using ChatSlide

This presentation explores the intricate relationship between obesity and obstructive sleep apnea (OSA), highlighting the emerging role of Tirzepatide in management. It delves into the pathophysiological impact of obesity on OSA, validated by a detailed patient case study. The efficacy of Tirzepatide in reducing obesity and its subsequent effects on OSA symptoms are examined through clinical trial data. A thorough clinical case review and analysis of current guidelines offer practical...